Managing severe epilepsy syndromes of early childhood is challenging as the seizures are typically resistant to treatment and may cause disabling mental and behavioral problems in later life. A comprehensive treatment plan includes pharma-cologic, nonpharmacologic, and surgical options. This article reviews clinical studies examining the efficacies of antiepilep-tic medications in reducing seizure frequency in Dravet syn-drome, Doose syndrome, and Lennox-Gastaut syndrome. The benefits of the ketogenic diet for children with these severe epilepsies, together with the advantages of vagus nerve stimu-lation and corpus callosotomy in those patients with Lennox-Gastaut syndrome, are also discussed. Special treat-ment considerations for each synd...
Lennox-Gastaut syndrome is one of the most severe epileptic encephalopathies of childhood onset. The...
The present study assessed the long-term(i.e., 24 months) efficacy of the ketogenic diet (KD) as an ...
Seizures are clinically significant manifestations associated with 79%-90% of patients with tuberous...
AbstractPurposeThe ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs)...
The severe epilepsies of childhood are described briefly and information available on the efficacy o...
Background and Aims: Ketogenic diet is currently a therapeutic option for the treatment of epilepsy ...
Epilepsy is the most frequent chronic neurological disorder in children and the majority of children...
Abstract: we present the experience of applying the methods of non-drug treatment drug-resistant epi...
Twenty to thirty percent of children with epilepsy continue to have seizures despite anti-epileptic ...
Childhood epilepsies comprise a heterogeneous group of disorders and syndromes that vary in terms of...
OBJECTIVE: Children with myoclonic astatic epilepsy (MAE; Doose syndrome) whose seizures do not resp...
Many children with epilepsy experience seizures that cannot be resolved with medication. Since surgi...
Kenou van RijckevorselReference Centre of Refractory Epilepsy, Cliniques Universitaires St Luc, Univ...
Is the ketogenic diet (KD) more effective in certain epilepsy syndromes? The KD has been shown to be...
Dravet syndrome is an infantile epilepsy syndrome with intractable pleomorphic seizures, cognitive i...
Lennox-Gastaut syndrome is one of the most severe epileptic encephalopathies of childhood onset. The...
The present study assessed the long-term(i.e., 24 months) efficacy of the ketogenic diet (KD) as an ...
Seizures are clinically significant manifestations associated with 79%-90% of patients with tuberous...
AbstractPurposeThe ketogenic diet (KD) has been used as an alternative to antiepileptic drugs (AEDs)...
The severe epilepsies of childhood are described briefly and information available on the efficacy o...
Background and Aims: Ketogenic diet is currently a therapeutic option for the treatment of epilepsy ...
Epilepsy is the most frequent chronic neurological disorder in children and the majority of children...
Abstract: we present the experience of applying the methods of non-drug treatment drug-resistant epi...
Twenty to thirty percent of children with epilepsy continue to have seizures despite anti-epileptic ...
Childhood epilepsies comprise a heterogeneous group of disorders and syndromes that vary in terms of...
OBJECTIVE: Children with myoclonic astatic epilepsy (MAE; Doose syndrome) whose seizures do not resp...
Many children with epilepsy experience seizures that cannot be resolved with medication. Since surgi...
Kenou van RijckevorselReference Centre of Refractory Epilepsy, Cliniques Universitaires St Luc, Univ...
Is the ketogenic diet (KD) more effective in certain epilepsy syndromes? The KD has been shown to be...
Dravet syndrome is an infantile epilepsy syndrome with intractable pleomorphic seizures, cognitive i...
Lennox-Gastaut syndrome is one of the most severe epileptic encephalopathies of childhood onset. The...
The present study assessed the long-term(i.e., 24 months) efficacy of the ketogenic diet (KD) as an ...
Seizures are clinically significant manifestations associated with 79%-90% of patients with tuberous...